Anti-IL-5 (mepolizumab) therapy does not alter IL-5 receptor alpha levels in patients with eosinophilic esophagitis
JournalItem (Reviews, Editorials, Rezensionen, Urteilsanmerkungen etc. in einer wissenschaftlichen Zeitschrift)
 
ID 1197804
Author(s) Conus, Sébastien; Straumann, Alex; Simon, Hans-Uwe
Author(s) at UniBasel Straumann, Alex
Year 2009
Title Anti-IL-5 (mepolizumab) therapy does not alter IL-5 receptor alpha levels in patients with eosinophilic esophagitis
Journal Journal of allergy and clinical immunology
Volume 123
Number 1
Pages 269; author reply 269-70
Publisher Mosby
ISSN/ISBN 0091-6749
edoc-URL http://edoc.unibas.ch/dok/A6007957
Full Text on edoc No
Digital Object Identifier DOI 10.1016/j.jaci.2008.09.031
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/18951621
ISI-Number WOS:000262793900049
Document type (ISI) Comment, Letter
 
   

MCSS v5.8 PRO. 0.428 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
08/08/2020